Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 10:56:101521.
doi: 10.1016/j.lanwpc.2025.101521. eCollection 2025 Mar.

FURLONG study: reply on the patient reported outcome measures and thresholds

Ahu Alanya  1 , Corneel Coens  1 , Dagmara Kuliś  1 , Jaap Reijneveld  2   3
Affiliations

FURLONG study: reply on the patient reported outcome measures and thresholds

Ahu Alanya et al. Lancet Reg Health West Pac. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

None.

References

    1. Shi Y., Chen G., Wang X., et al. Patient-reported outcomes for the phase 3 FURLONG study of furmonertinib versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer. Lancet Reg Health West Pac. 2024;48 doi: 10.1016/j.lanwpc.2024.101122. - DOI - PMC - PubMed
    1. Koller M., Shamieh O., Hjermstad M.J., et al. "Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study". Lancet Oncol. 2020;21(5):723–732. - PubMed
    1. Kuliś D., Bottomley A., Whittaker C., et al. The use of the EORTC item library to supplement EORTC quality of life instruments. Value Health. 2017;20(9):PA775. doi: 10.1016/j.jval.2017.08.2236. - DOI
    1. Coon C.D., Schlichting M., Zhang X. Interpreting within-patient changes on the EORTC QLQ-C30 and EORTC QLQ-LC13. Patient. 2022;15(6):691–702. Epub 2022 Jun 30. PMID: 35771392; PMCID: PMC9585005. - PMC - PubMed
    1. Musoro J.Z., Coens C., Sprangers M.A.G., et al. "Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: a synthesis across 21 clinical trials involving nine different cancer types". Eur J Cancer. 2023;188:171–182. - PubMed

LinkOut - more resources